Kazumasa Fujitani - Department of Surgery, Osaka National Hospital

基本信息

浏览量：114

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 327 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Phase II Trial of Trastuzumab Combined with Irinotecan in Patients with Advanced HER2-positive Chemotherapy-refractory Gastric Cancer (OGSG1203 HERBIS-5): Final Results

Junji Kawada,Daisuke Sakai,Yutaka Kimura,Motohiro Hirao,Kazuhiro Nishikawa,Naotoshi Sugimoto,Yoshio Oka,Shunji Endo,Yutaka Isozaki,Jin Matsuyama,Ryohei Kawabata,Tomono Kawase,Kazumasa Fujitani,Yukinori Kurokawa,Hisato Kawakami,Toshio Shimokawa,Taroh Satoh, Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)

Anticancer researchno. 3 (2025): 1077-1085

引用0浏览0WOS引用

Salvage-line of Capecitabine Plus Oxaliplatin Therapy (XELOX) for Patients with Inoperable/Advanced Gastric Cancer Resistant/Intolerant to Cisplatin (OGSG1403)

Naotoshi Sugimoto,Junji Kawada, Yoshio Oka,Shugo Ueda,Kohei Murakami,Kazuhiro Nishikawa,Yukinori Kurokawa,Kazumasa Fujitani,Hisato Kawakami,Shunji Endo,Daisuke Sakai, Toshio Shimokawa,Taroh Satoh

ANTICANCER RESEARCHno. 1 (2025): 307-313

引用0浏览0WOS引用

Comparison of Laparoscopic and Open Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: a Propensity Score Matching Analysis

Keijiro Sugimura,Masaaki Motoori,Kishi Kentaro,Kazuyoshi Yamamoto,Atsushi Takeno,Hisashi Hara,Takuya Hamakawa,Kohei Murakami,Yujiro Nakahara, Toru Masuzawa,Takeshi Omori,Yukinori Kurokawa,Kazumasa Fujitani,Yuichiro Doki

Surgical Endoscopyno. 4 (2025): 2304-2315

引用0浏览0WOS引用

ASO Author Reflections: Prognostic Impact of Postoperative Oral Nutritional Supplements in Gastric Cancer

Takeshi Omori,Kazuyoshi Yamamoto,Yukinori Kurokawa,Yasuhiro Miyazaki,Kazumasa Fujitani,Ryohei Kawabata,Hiroshi Imamura,Atsushi Takeno,Yoshitomo Yanagimoto,Tsuyoshi Takahashi,Takuro Saito,Hidetoshi Eguchi,Yuichiro Doki

Annals of Surgical Oncologypp.1-2, (2024)

引用0浏览0WOS引用

Prognostic Factors of Conversion Surgery for Stage IV Gastric Cancer: A Multi‐institutional Retrospective Analysis

Atsushi Takeno,Masaaki Motoori,Kentaro Kishi,Takeshi Omori,Motohiro Hirao, Toru Masuzawa,Kazumasa Fujitani, Kazuyoshi Yamamato,Yukinori Kurokawa,Yuichiro Doki

ANNALS OF GASTROENTEROLOGICAL SURGERYno. 3 (2024): 431-442

引用0浏览0WOS引用

Efficacy of Adjuvant Chemotherapy after Curative Hepatectomy for Patients with Colorectal Cancer Liver Metastases: a Single-Center Retrospective Study

Akira Inoue,Yujiro Nishizawa, Masahiro Hashimoto,Yuki Ozato, Yoshihiro Morimoto,Akira Tomokuni,Masaaki Motoori,Kazumasa Fujitani

World Journal of Surgical Oncologyno. 1 (2024): 1-8

引用0浏览0WOS引用

Prospective Single-Arm Multicenter Interventional Study of Surgical Resection for Liver Metastasis from Gastric Cancer; 3-Year Overall and Recurrence-Free Survival

Kazumasa Fujitani,Yukinori Kurokawa,Ryohei Wada,Atsushi Takeno,Ryohei Kawabata,Takeshi Omori,Hiroshi Imamura,Motohiro Hirao,Shunji Endo,Junji Kawada,Jeong Ho Moon,Shuji Takiguchi,Masaki Mori,Hidetoshi Eguchi,Yuichiro Doki

European Journal of Cancer (2024): 115080

引用0浏览0WOS引用

Clinical Impact of Conversion Surgery after Induction Therapy for Esophageal Cancer with Synchronous Distant Metastasis: A Multi-institutional Retrospective Study

Keijiro Sugimura,Koji Tanaka,Takahito Sugase,Kota Momose,Takashi Kanemura,Kotaro Yamashita,Tomoki Makino,Osamu Shiraishi,Masaaki Motoori,Makoto Yamasaki,Hiroshi Miyata,Kazumasa Fujitani,Takushi Yasuda,Masahiko Yano,Hidetoshi Eguchi,Yuichiro Doki

ANNALS OF SURGICAL ONCOLOGY（2024）

引用0浏览0WOS引用

Meta-analysis of Biweekly Irinotecan Plus Cisplatin Versus Irinotecan Alone As Second-Line Treatment for Advanced Gastric Cancer

Kazuhiro Nishikawa,Wasaburo Koizumi,Akira Tsuburaya,Motoko Suzuki,Satoshi Morita,Kazumasa Fujitani,Yusuke Akamaru,Ken Shimada,Hisashi Hosaka,Ken Nishimura,Takaki Yoshikawa,Toshimasa Tsujinaka,Junichi Sakamoto

International journal of clinical oncology（2024）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn